prikaz prve stranice dokumenta Indications, Complications, and Outcomes of Cardiac Surgery After Heart Transplantation: Results From the Cash Study
  Download
PDF 1.71 MB
Scientific paper - Original scientific paper
Indications, Complications, and Outcomes of Cardiac Surgery After Heart Transplantation: Results From the Cash Study
Frontiers in Cardiovascular Medicine, 10 (2022); 879612. https://doi.org/10.3389/fcvm.2022.879612
Gökler, Johannes; Aliabadi-Zuckermann, Arezu Z.; Kaider, Alexandra; Ambardekar, Amrut V.; Antretter, Herwig; Artemiou, Panagiotis; Bertolotti, Alejandro M.; Boeken, Udo; Brossa, Vicens; Copeland, Hannah; Generosa Crespo-Leiro, Maria; Eixeré-Esteve, Andrea; Epailly, Eric; Farag, Mina; Hulman, Michal; Khush, Kiran K.; Masetti, Marco; Patel, Jignesh; Ross, Heather J.; Rudež, Igor; Silvestry, Scott; Suarez, Sofia Martin; Vest, Amanda; Zuckermann, Andreas O. More authors...

Cite this document

Gökler, J., Aliabadi Zuckermann, A. Z., Kaider, A., Ambardekar, A. V., Antretter, H., Artemiou, P. ... Zuckermann, A. O. (2022). Indications, Complications, and Outcomes of Cardiac Surgery After Heart Transplantation: Results From the Cash Study. Frontiers in Cardiovascular Medicine, 10.. doi: 10.3389/fcvm.2022.879612

Gökler, Johannes, et al. "Indications, Complications, and Outcomes of Cardiac Surgery After Heart Transplantation: Results From the Cash Study." Frontiers in Cardiovascular Medicine, vol. 10, 2022. https://doi.org/10.3389/fcvm.2022.879612

Gökler, Johannes, Arezu Z. Aliabadi Zuckermann, Alexandra Kaider, Amrut V. Ambardekar, Herwig Antretter, Panagiotis Artemiou, Alejandro M. Bertolotti, et al. "Indications, Complications, and Outcomes of Cardiac Surgery After Heart Transplantation: Results From the Cash Study." Frontiers in Cardiovascular Medicine 10 (2022). https://doi.org/10.3389/fcvm.2022.879612

Gökler, J., et al. (2022) 'Indications, Complications, and Outcomes of Cardiac Surgery After Heart Transplantation: Results From the Cash Study', Frontiers in Cardiovascular Medicine, 10. doi: 10.3389/fcvm.2022.879612

Gökler J, Aliabadi Zuckermann AZ, Kaider A, Ambardekar AV, Antretter H, Artemiou P, and sur.. Indications, Complications, and Outcomes of Cardiac Surgery After Heart Transplantation: Results From the Cash Study. Frontiers in Cardiovascular Medicine [Internet]. 2022 May 09 [cited 2024 July 11];10. doi: 10.3389/fcvm.2022.879612

J. Gökler, et al., "Indications, Complications, and Outcomes of Cardiac Surgery After Heart Transplantation: Results From the Cash Study", Frontiers in Cardiovascular Medicine, vol. 10, May 2022. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:105:199721. [Accessed: 11 July 2024]

Please login to the repository to save this object to your list.
Metadata
Title (english)Indications, Complications, and Outcomes of Cardiac Surgery After Heart Transplantation: Results From the Cash Study
AuthorJohannes Gökler
AuthorArezu Z. Aliabadi-Zuckermann
AuthorAlexandra Kaider
AuthorAmrut V. Ambardekar
AuthorHerwig Antretter
AuthorPanagiotis Artemiou
AuthorAlejandro M. Bertolotti
AuthorUdo Boeken
AuthorVicens Brossa
AuthorHannah Copeland
AuthorMaria Generosa Crespo-Leiro
AuthorAndrea Eixeré-Esteve
AuthorEric Epailly
AuthorMina Farag
AuthorMichal Hulman
AuthorKiran K. Khush
AuthorMarco Masetti
AuthorJignesh Patel
AuthorHeather J. Ross
AuthorIgor Rudež
AuthorScott Silvestry
AuthorSofia Martin Suarez
AuthorAmanda Vest
AuthorAndreas O. Zuckermann
Author's institutionUniversity of Zagreb
School of Medicine
(Department of Surgery)
Scientific / art field,
discipline and subdiscipline		BIOMEDICINE AND HEALTHCARE
Clinical Medical Sciences
Surgery
Abstract (english)
Background: Allograft pathologies, such as valvular, coronary artery, or aortic disease, may occur early and late after cardiac transplantation. Cardiac surgery after heart transplantation (CASH) may be an option to improve quality of life and allograft function and prolong survival. Experience with CASH, however, has been limited to single-center reports. ----- Methods: We performed a retrospective, multicenter study of heart transplant recipients with CASH between January 1984 and December 2020. In this study, 60 high-volume cardiac transplant centers were invited to participate. ----- Results: Data were available from 19 centers in North America (n = 7), South America (n = 1), and Europe (n = 11), with a total of 110 patients. A median of 3 (IQR 2-8.5) operations was reported by each center; five centers included ≥ 10 patients. Indications for CASH were valvular disease (n = 62), coronary artery disease (CAD) (n = 16), constrictive pericarditis (n = 17), aortic pathology (n = 13), and myxoma (n = 2). The median age at CASH was 57.7 (47.8-63.1) years, with a median time from transplant to CASH of 4.4 (1-9.6) years. Reoperation within the first year after transplantation was performed in 24.5%. In-hospital mortality was 9.1% (n = 10). 1-year survival was 86.2% and median follow-up was 8.2 (3.8-14.6) years. The most frequent perioperative complications were acute kidney injury and bleeding revision in 18 and 9.1%, respectively. ----- Conclusion: Cardiac surgery after heart transplantation has low in-hospital mortality and postoperative complications in carefully selected patients. The incidence and type of CASH vary between international centers. Risk factors for the worse outcome are higher European System for Cardiac Operative Risk Evaluation (EuroSCORE II) and postoperative renal failure.
Keywords (english)
Languageenglish
Publication typeScientific paper - Original scientific paper
Publication statusPublished
Peer reviewPeer review
Publication versionPublished version
Journal titleFrontiers in Cardiovascular Medicine
Numberingvol. 10, 879612
e-ISSN2297-055X
DOIhttps://doi.org/10.3389/fcvm.2022.879612
URN:NBNurn:nbn:hr:105:199721
Publication2022-05-09
Document URLhttps://www.frontiersin.org/articles/10.3389/fcvm.2022.879612/full
Type of resourceText
Access conditionsOpen access
Terms of useLicence Attribution 4.0 International (CC BY 4.0) icon
Created on2022-12-05 10:43:40